...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: This gets me thinking Resverlogix is in sombody's sights.
2
Nov 15, 2016 04:05PM
3
Nov 15, 2016 04:58PM

Coldnewfie,

I was very confused by that bolded statement as well.

BearDownAZ

Share
New Message
Please login to post a reply